Breast Neoplasms: all 12,820 studies

Page 33 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast CancerCompletedNCT03831711Phase 1/2Results posted
• Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast CancerCompletedNCT03822468Phase 2Results posted
• Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast CancerActive, not recruitingNCT03820141Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerCompletedNCT03800836Phase 1Results posted
• NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast CancerActive, not recruitingNCT03789110Phase 2Results posted
• Study of Euthyroid Hypothyroxinemia in Metastatic Breast CarcinomaTerminatedNCT03787303Phase 2Results posted
• Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerTerminatedNCT03786094Phase 3Results posted
• ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast CancerCompletedNCT03785782Results posted
• Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled TrialCompletedNCT03783546Not applicableResults posted
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerCompletedNCT03778931Phase 3Results posted
• Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast CancerCompletedNCT03774472Phase 1/2Results posted
• MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast CancerCompletedNCT03767335Phase 1Results posted
• Increasing Patients' Engagement in Breast Cancer Surgery Decision-MakingCompletedNCT03766009Not applicableResults posted
• Effectiveness of Taping on Anastomotic Regions in Patients With Breast Cancer-Related LymphoedemaCompletedNCT03765996Not applicableResults posted
• GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain MetastasesTerminatedNCT03765983Phase 2Results posted
• Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast CancerCompletedNCT03755141Phase 2Results posted
• Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant ChemotherapyTerminatedNCT03750240Not applicableResults posted
• Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]Active, not recruitingNCT03747120Phase 2Results posted
• A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to PoziotinibTerminatedNCT03744715Phase 2Results posted
• Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)CompletedNCT03742986Phase 2Results posted
• A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast CancerActive, not recruitingNCT03742102Phase 1/2Results posted
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]CompletedNCT03734029Phase 3Results posted
• ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast CancerTerminatedNCT03733119Phase 2Results posted
• A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast CancerCompletedNCT03726879Phase 3Results posted
• Reducing Metabolic Syndrome Among Breast Cancer SurvivorsCompletedNCT03719677Not applicableResults posted
• Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph NodesTerminatedNCT03718455Not applicableResults posted
• Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCISCompletedNCT03703492Phase 2Results posted
• A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast CancerCompletedNCT03703466Phase 2Results posted
• Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast CancerTerminatedNCT03697551Phase 2Results posted
• Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone MetastasisCompletedNCT03691493Phase 2Results posted
• Investigation of Novel Surgical Imaging for Tumor ExcisionCompletedNCT03686215Phase 3Results posted
• PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminatedNCT03685591Phase 1Results posted
• Radiofrequency Chip for Localization of Non-Palpable Breast LesionsCompletedNCT03684408Not applicableResults posted
• Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life DatabasesCompletedNCT03676257Results posted
• Vaccine-Based Immunotherapy Regimen For NSCLC and TNBCTerminatedNCT03674827Phase 1Results posted
• Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabCompletedNCT03674567Phase 1/2Results posted
• A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerCompletedNCT03674112Phase 2Results posted
• Safety of Pregnancy in BRCA Mutated Breast Cancer PatientsCompletedNCT03673306Results posted
• Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.CompletedNCT03671330Phase 2Results posted
• The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has SpreadCompletedNCT03659136Phase 2Results posted
• Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing MastectomyCompletedNCT03657069Not applicableResults posted
• Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast CancerCompletedNCT03650803Not applicableResults posted
• Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast CancerTerminatedNCT03648983Not applicableResults posted
• To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)CompletedNCT03644186Phase 2Results posted
• Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast CancerActive, not recruitingNCT03639948Phase 2Results posted
• A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast CancerTerminatedNCT03632941Phase 2Results posted
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• Implementation of the Begin Exploring Fertility Options, Risks and Expectations (BEFORE) Decision AidCompletedNCT03629509Not applicableResults posted
• Addressing Sexual Concerns in Breast Cancer: Patient Intervention StudyCompletedNCT03624972Not applicableResults posted
• The ConnectedCancerCare Pilot Study (CCC)CompletedNCT03618017Not applicableResults posted
• Narrative Visualization for Breast Cancer Survivors' Physical ActivityCompletedNCT03612596Not applicableResults posted
• Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard PaddleCompletedNCT03611543Results posted
• THRIVE Breast Cancer App StudyCompletedNCT03592771Not applicableResults posted
• Study to Investigate the Effect of AB-101 in Breast Cancer SurvivorsCompletedNCT03592121Early Phase 1Results posted
• ATOP TRIAL: T-DM1 in HER2 Positive Breast CancerActive, not recruitingNCT03587740Phase 2Results posted
• Fujifilm Feature Comparison Reader Study to Compare Old vs New ProcessingCompletedNCT03586583Results posted
• A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor TherapyTerminatedNCT03584009Phase 2Results posted
• Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in ChinaCompletedNCT03575065Phase 2Results posted
• The Prone to Supine Breast MRI TrialCompletedNCT03573804Not applicableResults posted
• Study to Evaluate CCS1477 in Advanced TumoursCompletedNCT03568656Phase 1/2Results posted
• CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast CancerActive, not recruitingNCT03568422Phase 1/2Results posted
• Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerTerminatedNCT03566485Phase 1/2Results posted
• Examining Bioactivity of PVSRIPO in Invasive Breast CancerCompletedNCT03564782Early Phase 1Results posted
• A Study of ZN-c5 in Subjects With Breast CancerCompletedNCT03560531Phase 1/2Results posted
• Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast CancerTerminatedNCT03560102Not applicableResults posted
• Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast CancerCompletedNCT03556358Phase 3Results posted
• A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following ChemotherapyCompletedNCT03542175Phase 1Results posted
• Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for SurgeryTerminatedNCT03535506Phase 2Results posted
• T-DM1 and Palbociclib for Metastatic HER2 Breast CancerCompletedNCT03530696Phase 2Results posted
• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]CompletedNCT03529110Phase 3Results posted
• DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]CompletedNCT03523585Phase 3Results posted
• A Study of PF-06873600 in People With CancerTerminatedNCT03519178Phase 1/2Results posted
• Translating Research Into Practice: Patient Navigation for Breast CancerCompletedNCT03514433Not applicableResults posted
• Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast CancerCompletedNCT03511378Phase 4Results posted
• Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast CancerTerminatedNCT03510988Not applicableResults posted
• Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast CancerCompletedNCT03505671Not applicableResults posted
• Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMDTerminatedNCT03501979Phase 2Results posted
• Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal StudyCompletedNCT03501693Results posted
• A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast CancerCompletedNCT03499899Phase 2Results posted
• Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast CancerTerminatedNCT03499353Phase 2Results posted
• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerTerminatedNCT03498716Phase 3Results posted
• Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer ScreeningCompletedNCT03495115Not applicableResults posted
• A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast CancerCompletedNCT03493854Phase 3Results posted
• Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast CancerCompletedNCT03491917Results posted
• OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual DiseaseCompletedNCT03487666Phase 2Results posted
• Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain MetastasisCompletedNCT03483012Phase 2Results posted
• Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer ScreeningCompletedNCT03482557Not applicableResults posted
• Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast CancerCompletedNCT03477396Phase 2Results posted
• Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes.CompletedNCT03475992Not applicableResults posted
• The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast CancerCompletedNCT03454529Phase 2Results posted
• Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast CancerCompletedNCT03451162Phase 1Results posted
• Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole and, in Patients With a PIK3CA Mutation, on Second-line Treatment With Alpelisib Plus FulvestrantTerminatedNCT03439046Phase 3Results posted
• Promoting Breast Cancer Screening in Women Who Survived Childhood CancerCompletedNCT03435380Not applicableResults posted
• Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic InstabilityActive, not recruitingNCT03428802Phase 2Results posted
• Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast CancerCompletedNCT03425656Phase 3Results posted
• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast CarcinomaActive, not recruitingNCT03422003Not applicableResults posted
• Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerActive, not recruitingNCT03414970Phase 3Results posted
• Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast CancerCompletedNCT03414684Phase 2Results posted
• The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerActive, not recruitingNCT03414658Phase 2Results posted
• ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaCompletedNCT03394027Phase 2Results posted

← Breast Neoplasms overview